The NIH-funded study on Hobamine, Inflammation Biomarker Response to Oral 2-Hydroxybenzylamine (2-HOBA) Acetate in Healthy Humans, received the Nutrition Research Project of the Year Award.
This study showed the impact of 2-HOBA (Hobamine) supplementation on inflammatory biomarkers in healthy individuals and addressed the concern of maintaining a balanced immune system to prevent the progression of several diseases associated with chronic inflammation. The findings of the study suggest that supplementing with 2 HOBA (Hobamine) can support a balanced immune system by enhancing inflammatory biomarkers in healthy individuals and reducing the levels of the protein TWEAK, which stimulates inflammation and tumor development.
“This interesting and well-designed study, funded by NIH, found that 2 HOBA (Hobamine) supplementation may promote a healthy balance of the immune system by improving inflammatory biomarkers in healthy individuals. Published in a peer review journal that indicates strong credibility, and it therefore provides opportunities for formulators and developers to add Hobamine, to their immune focused formulations, enabling healthy individuals to be more proactive about maintaining their immune readiness. The novelty of the ingredient and the impacts on inflammatory markers in healthy people really helped this project stand out,” stated Stephen Daniells, PhD, Editor-in-Chief of NutraIngredients-USA. (Source: TSI Group)
